Anti Diabetic Effect of CL 316,243 (a β3-adrenergic Agonist) by Down Regulation of Tumour Necrosis Factor (TNF-α) Expression

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2012 Oct 12

PMID 23056223

Citations 10

Authors

Masoud Ghorbani

Mehdi Shafiee Ardestani

Sedigheh Hatami Gigloo

Reza Ahangari Cohan

Davoud Nouri Inanlou

Peyman Ghorbani

Affiliations

Soon will be listed here.

Abstract

Objective: Obesity is a risk factor for the development of insulin resistance and is one of the most important contributors to the pathogenesis of type 2 diabetes, which acts mainly through the secretion of adipokines such as TNF-α that may influence insulin sensitivity. TNF-α affects many aspects of adipocyte function, such as adipocyte development and lipid metabolism.

Material And Methods: We demonstrated that there is a correlation between the expressions of TNF-α in retroperitoneal WAT and insulin-resistance in 8 genetically obese fa/fa rats. Treatment of animals with CL 316,243, a β3-adrenergic agonist, showed an improvement of insulin-resistance that was linked with the suppression of TNF-α mRNA expression in WAT.

Results: These results confirm the association between TNF-α expression and the insulin-resistant condition in rats. Our finding indicates that the hyperglycaemia and hyperinsulinemia induced by insulin-resistance correlated positively with the expression of TNF-α mRNA in an abdominal WAT depot.

Conclusion: We conclude that CL 316,243 possesses both anti-diabetic effects and anti-obesity effects in rodents.

Citing Articles

Brown adipose tissue-derived MaR2 contributes to cold-induced resolution of inflammation.

Sugimoto S, Mena H, Sansbury B, Kobayashi S, Tsuji T, Wang C Nat Metab. 2022; 4(6):775-790.

PMID: 35760872 PMC: 9792164. DOI: 10.1038/s42255-022-00590-0.

Repurposing beta-3 adrenergic receptor agonists for Alzheimer's disease: beneficial effects in a mouse model.

Tournissac M, Vu T, Vrabic N, Hozer C, Tremblay C, Melancon K Alzheimers Res Ther. 2021; 13(1):103.

PMID: 34020681 PMC: 8140479. DOI: 10.1186/s13195-021-00842-3.

Adult Hippocampal Neurogenesis Can Be Enhanced by Cold Challenge Independently From Beigeing Effects.

Kim J, Han K, Kim W, Jung H, Nam S, Yoo D Front Neurosci. 2019; 13:92.

PMID: 30890905 PMC: 6411820. DOI: 10.3389/fnins.2019.00092.

Beta 3 Adrenergic Receptor Activation Rescues Metabolic Dysfunction in Female Estrogen Receptor Alpha-Null Mice.

Clookey S, Welly R, Shay D, Woodford M, Fritsche K, Rector R Front Physiol. 2019; 10:9.

PMID: 30804793 PMC: 6371032. DOI: 10.3389/fphys.2019.00009.

β-Adrenergically induced glucose uptake in brown adipose tissue is independent of UCP1 presence or activity: Mediation through the mTOR pathway.

Olsen J, Csikasz R, Dehvari N, Lu L, Sandstrom A, Oberg A Mol Metab. 2017; 6(6):611-619.

PMID: 28580291 PMC: 5444022. DOI: 10.1016/j.molmet.2017.02.006.

References

Hotamisligil G . Inflammation and metabolic disorders. Nature. 2006; 444(7121):860-7. DOI: 10.1038/nature05485. View

Hotamisligil G, Peraldi P, Budavari A, Ellis R, White M, Spiegelman B . IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science. 1996; 271(5249):665-8. DOI: 10.1126/science.271.5249.665. View

Fu L, Isobe K, Zeng Q, Suzukawa K, Takekoshi K, Kawakami Y . The effects of beta(3)-adrenoceptor agonist CL-316,243 on adiponectin, adiponectin receptors and tumor necrosis factor-alpha expressions in adipose tissues of obese diabetic KKAy mice. Eur J Pharmacol. 2008; 584(1):202-6. DOI: 10.1016/j.ejphar.2008.01.028. View

Lowell B, Hamann A, Lawitts J, Himms-Hagen J, Boyer B, Kozak L . Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature. 1993; 366(6457):740-2. DOI: 10.1038/366740a0. View

Howard G, Bergman R, Wagenknecht L, Haffner S, Savage P, Saad M . Ability of alternative indices of insulin sensitivity to predict cardiovascular risk: comparison with the "minimal model". Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Ann Epidemiol. 1998; 8(6):358-69. DOI: 10.1016/s1047-2797(98)00002-7. View

Ghorbani M, Himms-Hagen J . Appearance of brown adipocytes in white adipose tissue during CL 316,243-induced reversal of obesity and diabetes in Zucker fa/fa rats. Int J Obes Relat Metab Disord. 1997; 21(6):465-75. DOI: 10.1038/sj.ijo.0800432. View

Hotamisligil G, Shargill N, Spiegelman B . Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993; 259(5091):87-91. DOI: 10.1126/science.7678183. View

Dallaire F, Atgie C, Mauriege P, Simard P, Bukowiecki L . Characterization of beta 1- and beta 3-adrenoceptors in intact brown adipocytes of the rat. Br J Pharmacol. 1995; 114(2):275-82. PMC: 1510265. DOI: 10.1111/j.1476-5381.1995.tb13223.x. View

Lang C, DOBRESCU C, Bagby G . Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology. 1992; 130(1):43-52. DOI: 10.1210/endo.130.1.1727716. View

10.

Hotamisligil G, Murray D, Choy L, Spiegelman B . Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci U S A. 1994; 91(11):4854-8. PMC: 43887. DOI: 10.1073/pnas.91.11.4854. View

11.

Spiegelman B, Choy L, Hotamisligil G, Graves R, Tontonoz P . Regulation of adipocyte gene expression in differentiation and syndromes of obesity/diabetes. J Biol Chem. 1993; 268(10):6823-6. View

12.

Hofmann C, Lorenz K, Braithwaite S, Colca J, Palazuk B, Hotamisligil G . Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance. Endocrinology. 1994; 134(1):264-70. DOI: 10.1210/endo.134.1.8275942. View

13.

Spiegelman B, Hotamisligil G . Through thick and thin: wasting, obesity, and TNF alpha. Cell. 1993; 73(4):625-7. DOI: 10.1016/0092-8674(93)90243-j. View

14.

Kim H, Pennisi P, Gavrilova O, Pack S, Jou W, Setser-Portas J . Effect of adipocyte beta3-adrenergic receptor activation on the type 2 diabetic MKR mice. Am J Physiol Endocrinol Metab. 2006; 290(6):E1227-36. DOI: 10.1152/ajpendo.00344.2005. View

15.

Kanety H, Feinstein R, Papa M, Hemi R, Karasik A . Tumor necrosis factor alpha-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1. J Biol Chem. 1995; 270(40):23780-4. DOI: 10.1074/jbc.270.40.23780. View

16.

Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28(7):412-9. DOI: 10.1007/BF00280883. View